Vegan Protein Powder Global Market Report 2023 – By Type (Soy Protein, Spirulina Protein, Wheat Protein, Pumpkin Seed Protein, Hemp Protein, Pea Protein, Rice Protein, Other Types), By Age Group (Millennials, Generation X, Baby Boomers), By Nature (Organic, Conventional), By Distribution Channel (Modern Groceries, Online Retail Or E-Commerce, Natural And Specialty Retail, Pharmacies And Drug Stores, Health Food Stores, Convenience Stores, Other Distribution Channels), By Application (Sports Nutrition, Additional Nutrition) – Market Size, Trends, And Global Forecast 2023-2032

Protein expression is a process in which proteins are synthesized, modified, regulated, and controlled in living organisms according to the host cell. Protein expression in the context of protein research can now also refer to the application of lab procedures necessary for protein production. The main product types for protein expression are reagents, competent cells, expression vectors, services, and instruments. A reagent is a substance or compound that is added to a system in order to produce a chemical reaction or to determine whether or not a reaction occurred. The various forms of protein expression include yeast expression, mammalian expression, algae expression, insect expression, bacterial expression, and cell-free expression that are used for therapeutic, industrial, and research applications. The different end users involve pharmaceutical and biotechnology companies, academic research, and contract research organizations. The global protein expression market is segmented - 1) By Protein Expression: Yeast Expression, Mammalian Expression, Algae Expression, Insect Expression, Bacterial Expression, Cell-free Expression 2) By End Use: Pharmaceutical And Biotechnological Companies, Academic Research, Contract Research Organizations 3) By Product: Reagents, Competent Cells, Expression vectors, Services, Instruments 4) By Application: Therapeutic, Industrial, Research The global protein expression market size will grow from $2.87 billion in 2022 to $3.19 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global protein expression is expected to grow to $4.96 billion in 2027 at a CAGR of 11.6%. An increase in demand for biologics to counter various genetic disorders and chronic diseases is one the major factors driving the research and sales of protein expression market. Biologics is a medicine produced from living organisms or contains components of living organisms such as protein, tissue, genes, allergens, cells, blood components, blood, and vaccines. The increasing use of biologics (therapeutic protein and others) to cure chronic diseases such as cancer, cardiovascular conditions and genetic disorders, is increasing the demand for protein expression devices and equipment. According to the World Health Organization, chronic disease prevalence rose by 57% globally, in the year 2020. Hence the rising demand for biologics is driving the protein expression market. For instance, according to an article published by Chemistry World, analysts stated that the biologics market hold a market share of more than a quarter of the entire pharmaceutical market in 2020. The global biologics market is expected to grow at 14.7% during 2021-2023. Major players in the protein expression market are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., New England Biolabs, Promega Corporation, Qiagen, Takara Bio, Merck KGaA, Genscript Biotech Corporation, Life Technologies Corporation, Sigma-Aldrich Corporation, Lucigen Corporation, Synthetic Genomics Inc., Becton, Dickinson & Company, Lonza Group Ltd., Accelagen Inc., Geneva Biotech, Viva Biotech, Becton, Dickinson & Company, Sengenics, ARTES Biotechnology GmbH, Addgene Inc., Profacgen, ProteoGenix, Peak Proteins Ltd., Domainex Ltd., Jena Bioscience GmbH, EMD Millipore, and Oxford Expression Technologies Ltd. Government regulations related to protein therapeutics and the production of biologics may hinder the protein expression market growth. Government regulations on biologics to undergo rigorous preclinical and clinical trials prior to regulatory approval, and time-consuming process for approval of biologics with regards to health and the safety of any individual are restraining the market growth. Marketing and distribution of biologics including insulin, hormones, therapeutic antibodies, and vaccines depends upon the successful completion of clinical trials, which is a long, expensive, and uncertain process. According to FDA, for an approval of new biologic, Under the regulations (21 CFR 314.81(b)(2)(vii) and 601.70, a clinical trial approval usually takes 10- 12 months where firms are required to submit a report annually on the status of clinical safety, clinical efficiency, clinical pharmacology, and nonclinical toxicology study. Companies in the industry are increasingly adopting Microfluidics technology to enhance protein expression tests in order to reduce the time, cost, labor, and increase in the accuracy and performance. The microfluidics technology effectively analyzes biological samples than the traditional (macroscale) instruments. Microfluidics technology is used to measure the expression of proteins on cells and optimizes the output to generate results regarding protein expression. Therapeutics-on-a-chip (TOC) uses microfluidic platform and is able to synthesize proteins in a point-of-care setting to reduce cost associated with storage and transportation of therapeutic proteins. For instance, companies such as MissionBio, NanoCellect Biomedical, RainDance Technologies and Sphere fluidics have implemented this technology in protein expression test. The Protein Expression market in the U.S. is governed by the Food and Drug Administration (FDA) which lays down a series of guidelines for the manufacturers and retailers of this industry. Within FDA, Centre for Drug Evaluation and research (CDER) regulates biological products under FDA 101 which includes gene therapy products and vaccines. These regulations ensure the quality, safety, and efficacy of biological therapeutics products, and speed up innovations that make these products safer, and effective. The US FDA announced a fast-track initiative to review its drugs and biologics policy to speed the availability of therapies to patients with serious conditions, orphan drugs for rare disease, while preserving the safety and efficacy standards. FDA also removed a rule (Section 610.21 of the FDA code) that specified minimal potency limits for certain antibodies and antigens. The European Medicines Agency has also introduced policies that include a provision to waive the scientific advice fee, which encourages more academic groups and small companies to propose candidates for biologics. North America was the largest region in the protein expression market in 2022. Western Europe was the second largest region in the global protein expression market share. The regions covered in the global protein expression market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the protein expression market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The protein expression market includes revenue earned by instruments, expression kits, and systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The protein expression market research report is one of a series of new reports from The Business Research Company that provides protein expression market statistics, including protein expression industry global market size, regional shares, competitors with a protein expression market share, detailed protein expression market segments, market trends and opportunities, and any further data you may need to thrive in the protein expression industry. This protein expression market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Vegan foods are foods that are produced without the use of animal ingredients or animal-derived ingredients. The global vegan food market is segmented - 1) By Product Substitute: Dairy Alternative, Meat Substitute, Other Product Substitutes 2) By Distribution Channel: Online, Offline 3) By Source: Wheat, Soy, Oats, Almond, Other Sources The global vegan food market size will grow from $16.05 billion in 2022 to $18.27 billion in 2023 at a compound annual growth rate (CAGR) of 13.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global vegan food is expected to grow from $29.19 billion in 2027 at a CAGR of 12.4%. An increase in concern about the environment among the population is driving the growth of the vegan food market. Rearing and breeding livestock such as pigs, hens, cows, and goats on farms contributes to the greenhouse effect. Greenhouse gases are released from the agriculture of livestock such as cows, and the gases are released to block the atmospheric heat from escaping, which increases the overall temperature. The demand for animal meat requires the excess practice of animal farming. Thus, an increase in the number of consumers of vegan food market eliminates the demand for excessive animal farming, following a decrease in greenhouse gas emissions in the environment. According to the United States Environmental Protection Agency, a US-based independent executive agency for the environment, in 2020, total greenhouse gas emissions were 5,981 million metric tons of carbon dioxide equivalent. Thus, an increase in concern about the environment among the population is driving the growth of the vegan food market. Major players in the vegan food market are Amy's Kitchen, Vitasoy International Holdings Ltd., Beyond Meat, Tofutti Brands, Plamil Foods Ltd., Danone S.A., Vbites Foods Ltd., Eden Foods Inc., Whitewave Foods Company Inc., Sun Opta Inc. Certain vegan food products lack certain nutrients. Vegan products do not contain any animal ingredients or animal-derived ingredients. Vegan food doesn't contain an adequate amount of high-quality protein and fats. Both vegan and vegetarian diets lack many very important minerals, such as calcium, iron, and zinc. According to a study published in 2020 by BMC Medicine, vegans have a higher fracture risk as compared to meat-eaters, fish-eaters, and vegetarians. The strongest associations were observed for hip fractures, for which fish eaters, vegetarians, and vegans all had higher risks. This is due to an inadequate calcium intake in a vegan diet. Therefore, the lack of essential nutrients impacts the growth of the vegan food market. One of the trends in the vegan food is the production of meat through cell-based technology. The cell-by-cell identical meat is produced in factories without involving the killing of animals. Production of cell-based meat involves feeding the animal cells with nutrients and proteins, thus eliminating the need for dependence on animals for meat. For instance, in October 2022, a US-based pet food manufacturer introduced the cellular-based meat broth topper for dogs known as chicken broth topper, which will replace factory-framed products with cruelty-free cell-based meet to challenges related to the low quality and contamination of pet food. Other major players such as Tyson Foods., an U.S.A. based processor and marketer of chicken, beef, and pork, are also investing in Memphis Meats in order to support the cell -based meat production. Asia-Pacific was the largest region in the vegan food market in 2022. Western Europe was the second-largest region in the vegan food market report. The regions covered in the vegan food industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The vegan food market consists of sales of vegan fruits and vegetables, legumes such as vegan peas, vegan beans, plant protein-based tofu, and plant protein-based meat. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The vegan food market research report is one of a series of new reports from The Business Research Company that provides vegan food market statistics, including global market size, regional shares, competitors with vegan food market share, detailed vegan food market segments, market trends and opportunities, and any further data you may need to thrive in the vegan food market industry. This vegan food market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Protein labelling refers to the process of detecting or purifying the labelled protein and its binding partners by using the proper molecular labels. Most biological research uses one of three basic categories of protein labels: biotin, enzyme conjugates, or fluorescence probes. The main types of products in protein labelling are reagents, proteins, enzymes, probes or tags, and monoclonal antibodies. Monoclonal antibodies are created by cloning a single white blood cell. Every subsequent antibody generated in this manner may be traced back to a single parent cell. The different labelling methods include in-vitro labeling, and in-vivo labelling and are used in cell-based assays, fluorescence microscopy, immunological techniques, mass spectrometry, and protein microassays. The global protein labelling market is segmented - 1) By Product: Reagents, Protein, Enzymes, Probes/ Tags, Monoclonal Antibodies 2) By Labeling Method: In-vitro Labeling, In-vivo Labeling 3) By Application: Cell Based-Assay, Fluorescence Microscopy, Immunological Techniques, Mass Spectrometry, Protein Micro Assay The global protein labelling market size will grow from $2.13 billion in 2022 to $2.35 billion in 2023 at a compound annual growth rate (CAGR) of 10.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global protein labelling is expected to grow from $3.49 billion in 2027 at a CAGR of 10.4%. Increased spending on the R&D of proteomics and genomics is driving the growth of the protein labelling reagents market. Proteomics is the study of the overall protein content of a cell, tissue, or organism. Protein labelling methods before separation and analysis are essential during proteomic profiling approaches. For instance, the National Institutes of Health (NIH) of the United States, funded $37 billion for biomedical research. This funding is for life sciences research that supports study at a molecular level for the understanding of fundamental processes by which diseases develop, the identification of biomarkers that signal the presence of disease, or identification of genes or proteins responsible for the disease. The Novo Nordisk Foundation granted a grant of up to $1.5 million to the University of Copenhagen to establish a mass spectrometry facility, which marks a new and exciting step in protein research. Therefore, the increased spending on research and development of proteomics and genomics is driving the market. Major players in the protein labelling market are Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer, Inc., General Electric Company, F. Hoffmann-La Roche AG, AGILENT TECHNOLOGIES INC., BIO-RAD LABORATORIES, Kirkegaard & Perry Laboratories, LI-COR Inc. and Kaneka Corporation. Drawbacks related to protein labelling techniques are expected to hinder the market. Label-free techniques are preferred over labelled techniques because of the drawbacks associated with them, such as wet-lab complexity and flexibility. While label-free samples can be measured without much preparation, wet lab pre-treatment is required for all labelling techniques. Samples must be labelled with metabolic (e.g. SILAC) or chemical (e.g. iTRAQ or TMT) reagents and the different conditions has to be combined. Therefore, label-free techniques are less prone to wet lab errors than labelling techniques. Label-free approaches have the advantage of being highly adaptable, even after the study has begun. New samples can be included at any time, but labelled approaches require the same number (n) of each condition. New samples may not be included in the study if they cannot be physically mixed and measured with the control. Labeled techniques such as the Super-SILAC approach reduce this problem but must also be carefully planned. These disadvantages are making label-free techniques preferable. Therefore, drawbacks associated with protein labeling techniques are expected to hinder the market. Companies in the protein labelling market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive market, companies are developing innovative products as well as sharing skills and expertise with other companies. While companies have long collaborated as well as academic and research institutions in this market by way of partnerships, in or out-licensing deals, this trend has been increasing over recent years. For instance, recombinant protein manufacturer enGenes Biotech GmbH (enGenes) announced a collaboration with ACIB GmbH for protein labeling. In January 2020, Abcam, a UK-based protein research tools producer and seller, announced its decision to acquire Expedeon's Proteomics and Immunology business, which includes Innova and TGR Biosciences. Expedeon technology supports a diverse set of labels, including enzymes, metals, oligos, and fluorescent proteins. Abcam will combine the newly acquired capture and conjugation technologies with its extensive antibody and protein expertise to expand and enhance its portfolio of off-the-shelf, and custom reagents and tools. Expedeon is a Germany-based manufacturer of protein discovery and analysis products used for protein and drug research. North America was the largest region in the protein labeling market in 2022. The regions covered in the global protein labelling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the protein labelling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The protein labeling market includes revenues earned by entities by detecting or purifying the labelled protein and its binding partners. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The protein labelling market research report is one of a series of new reports from The Business Research Company that provides protein labelling market statistics, including the industry's global market size, regional shares, competitors with a protein labelling market share, detailed protein labelling market segments, market trends and opportunities, and any further data you may need to thrive in the protein labelling industry. This protein labelling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Protein inhibitors refer to compounds that interfere with the steps directly involved in the production of new proteins in cells. Protein inhibitors operate at the ribosome level, benefiting from the significant variations between prokaryotic and eukaryotic ribosome architectures. The main product types of protein inhibitors are protein kinase inhibitors, monoclonal antibodies, and others. Monoclonal antibodies are laboratory-created molecules designed to act as substitute antibodies, restoring, enhancing, modifying, or mimicking the immune system's attack on unwanted cells, such as cancer cells. The protein inhibitors are used in the treatment of oncology, inflammatory diseases, and others, and are distributed by hospital pharmacies, independent pharmacies, and online pharmacies. The global protein inhibitors market is segmented - 1)By Product: Protein Kinase Inhibitors, Monoclonal Antibody, Other Products 2) By Application: Oncology, Inflamatory Diseases, Other Applications 3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies The global protein inhibitors market size grew from $68.17 billion in 2022 to $74.3 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the protein inhibitors is expected to grow from $105.43 billion in 2027 at a CAGR of 9.1%. The increasing prevalence of chronic diseases is predicted to contribute to the growth of the protein inhibitors market over the forecast period. Chronic diseases such as cancer, cardiovascular diseases, and autoimmune diseases are becoming more prevalent. For instance, in May 2022, according to the World Health Organization, chronic diseases are expected to become the seventh leading cause of death globally by the end of 2030.In the USA, the number reached 157 million in 2020, with 87 million people having multiple conditions. Protein inhibitors are used for the treatment of these diseases attributing to fewer adverse effects and higher efficacy. Therefore, an increasing number of people with chronic diseases are anticipated to propel the demand for growth of the protein inhibitors market. Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche, Teva, Apotex, Novartis, GlaxoSmithKline, Pfizer, Boehringer Ingelheim, and F. Hoffmann-La Roche. The high cost of protein inhibitors used for cancer is anticipated to limit the growth of the protein inhibitors market shortly. Monoclonal antibodies are a type of protein made in the laboratory to bind substances in the body including cancer cells and are used to treat various types of cancer. Monoclonal antibody therapies are considered to be costlier when used for cancer. For instance, according to the National Center for Biotechnology Information, the average price of monoclonal antibodies was $96,731 for 34 monoclonal antibody indication combinations. Oncology and hematology monoclonal antibodies represented 40% of approved monoclonal antibody indication combinations, yet accounted for more than 85% of those priced at $100,000 or higher. The price of oncology or hematology monoclonal antibodies was $149,622 higher than those used in metabolic or cardiovascular disorders, $106,830 higher than in ophthalmology, $128,856 higher than in infectious diseases or allergies, and $98,981 higher than in immunology. Thus, the high cost of protein inhibitors including monoclonal antibodies for the treatment of cancer is expected to hinder the market’s growth. Companies in the protein inhibitors market are increasingly investing in various strategic initiatives such as partnerships and collaborations to develop new drugs to meet the market demand. Strategic collaborations and partnership agreements help companies to expand their existing product portfolio and geographical presence. For instance, in February 2020, Catalent, Inc., a USA-based provider of delivery technologies, drug manufacturing, gene therapies, biologics, and consumer healthcare products announced a partnership agreement with Zumutor Biologics Inc., an immune-oncology company based in the USA to manufacture ZM008, a monoclonal antibody targeting solid tumors. Moreover, in February 2021, Eli Lilly and Company, a USA-based pharmaceutical company, and Rigel Pharmaceuticals, Inc., a USA-based biotechnology company, announced a global exclusive license agreement and strategic collaboration to co-develop and commercialize Rigel's R552, a receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor, for all indications, including autoimmune and inflammatory diseases. In June 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology company, acquired ReViral for $525 million. The acquisition strengthens Pfizer's commitment to creating both medications and vaccines to help fight the respiratory syncytial virus while also expanding its anti-infective portfolio (RSV). ReViral is a UK-based clinical-stage biopharmaceutical company pioneering in the discovery and development of innovative antiviral drugs for disorders brought on by the respiratory syncytial virus. North America was the largest region in the protein inhibitors market in 2022. The regions covered in the global protein inhibitors market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the global protein inhibitors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The protein inhibitors market consists of sales of erythromycin, tetracycline, chloramphenicol, and aminoglycosides. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The protein inhibitors market research report is one of a series of new reports from The Business Research Company that provides protein inhibitors market statistics, including protein inhibitors industry global market size, regional shares, competitors with a protein inhibitors market share, detailed protein inhibitors market segments, market trends and opportunities, and any further data you may need to thrive in the protein inhibitors industry. This protein inhibitors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Protein supplements refer to a nutritional supplement that contains protein and is intended to supplement the diet. A protein supplement helps in building muscle, repairing tissue, and producing enzymes and hormones. It also aids in weight loss and assists in toning of muscles for athletes. The main types of protein supplements include protein powder, protein bars, and ready-to-drink products. Protein powder refers to powdered forms of protein that are derived from plants (soybeans, peas, rice, potatoes, or hemp), eggs, or milk (casein or whey protein). Other components, such as extra sugar, artificial flavors, thickeners, vitamins, and minerals, are added to enhance the flavor and functionality of the powder. Based on raw material, the protein supplements are differentiated by casein protein supplements, whey protein supplements, egg protein supplements, MPC protein supplements, and soy protein supplements. The animal-derived and plant-derived protein supplements are sold through supermarkets, hypermarkets, online stores, and drug stores. The global protein supplements market is segmented - 1) By Type: Protein Powder, Protein Bar, Ready to Drink 2) By Source: Plant-based, Animal-based 3) By Raw Material: Casein Protein Supplements, Whey Protein Supplements, Egg Protein Supplements, MPC Protein Supplements, Soy Protein Supplements 4) By Distribution Channel: Supermarkets & Hypermarkets, Online Stores, Drug Stores The global protein supplements market size grew from $18.75 billion in 2022 to $20.62 billion in 2023 at a compound annual growth rate (CAGR) of 10.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The market size of the global protein supplements is expected to grow to $29.51 billion in 2027 at a CAGR of 9.4%. The rise in customer preference for food supplements is driving the protein supplements market. Food Supplements are intended to make up for dietary deficiencies among individuals through their regular diet. The desire to lead active and healthy lifestyles has increased participation in sports and fitness activities, driving the demand for food supplements, especially protein supplements. According to the Council for Responsible Nutrition survey 2020, a US-based trade association for ingredient suppliers and manufacturers in the dietary supplement industry, approximately 43% of supplement users have altered their supplement regimens after the pandemic, whereas 91% of these users report an increase in supplement intake, including the addition of new supplements to an existing routine (46%), the taking of the same supplements more frequently (25%), or the increasing of doses (22%). Thus, an increase in customer preference for food supplements is expected to boost the demand for protein supplements during the forecast period. Major players in the protein supplements market are GlaxoSmithKline (GSK), Glanbia PLC, ABBOTT LABORATORIES (ABBOTT), Amway Corporation, Herbalife International of America, Inc., PepsiCo, AMCO Proteins, QuestNutrition, GNC Holdings, Maker Nutrition LLC, SUPPLEFORM, Vitaco Health Limited, Garden of Life, Melaleuca Inc., Atlantic Multipower UK Limited, International Dehydrated Foods, Inc., Scitec Nutrition, and BRF. Strategic partnership is a key trend gaining popularity in the protein supplements market. The companies operating in the protein supplement sector are focusing on entering into strategic partnerships to expand their market reach and leverage each other's resources in new product development & marketing activities. In October 2021, a New Jersey-based company that creates collagen supplements entered into a partnership with Entenmann's, owed by Bimbo Bakeries USA. The partnership aims to create a new collagen protein powder with Entenmann's chocolate chip cookies as inspiration. Entenmann is a US-based company that manufactures and delivers baked goods. In February 2022, Nestle Health Sciences, a Switzerland-based provider of nutrition solutions, diagnostics devices, and drugs for specific target areas acquired a majority stake in Orgain, for an undisclosed amount. Through this, Nestle is focused on expanding its product portfolio in the plant-based protein supplement sector and enhancing its business presence in the fast-growing plant-based product sector across the globe. Orgain is a California-based provider of plant-based nutritional products. North America was the largest region in the protein supplements market in 2022. Asia-Pacific is expected to be the fastest-growing region in the protein supplements market share duirng the forecast period. The regions covered in the protein supplements market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the protein supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The protein supplements market consists of sales of soybean meal, essential amino acid, protein intake, proteins, amino acids, whey protein. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The protein supplements market research report is one of a series of new reports from The Business Research Company that provides protein supplements market statistics, including protein supplements industry global market size, regional shares, competitors with a protein supplements market share, detailed protein supplements market segments, market trends and opportunities, and any further data you may need to thrive in the protein supplements industry. This protein supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The protein shampoo is a shampoo enriched with keratin to provide additional keratin to the hair follicles that coat the hair strands and provide protection to the hair. The protein shampoo market consists of the sales of protein shampoo is used as cosmetic products in human hair care. Protein shampoo products consist of keratin protein, collagen, and silk, which assist in increasing the elasticity of hair and strengthening, nourishing, and cleansing the hair. The main products of the protein shampoo are standard protein shampoo, anti-dandruff protein shampoo, anti-frizz protein shampoo, and other products. Standard protein shampoo refers to a type of shampoo designed to cleanse, strengthen and increase the elasticity of the hair. The ingredients used in protein shampoo include natural and organic, and chemicals. The various distribution channels involved in protein shampoo include online, hypermarkets and supermarkets, pharmaceutical and drug stores, and other distribution. The end-users of protein shampoo include adults and kids. The global protein shampoo market is segmented – 1) By Product: Standard Protein Shampoo, Anti-dandruff Protein Shampoo, Anti-frizz Protein Shampoo, Other Products 2) By Ingredient: Natural and Organic, Chemical-based 3) By Distribution Channel: Online, E-commerce Websites, Company-owned Websites, Offline, Hypermarkets and Supermarkets, Pharmaceutical and Drug Stores, Other Distribution Channels 4) By End User: Adults, Kids The global protein shampoo market size will grow from $1.79 billion in 2022 to $1.94 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of protein shampoo is expected to grow to $2.69 billion in 2027 at a CAGR of 8.5%. An increasing prevalence of hair and scalp-related diseases is expected to propel the growth of the protein shampoo market going forward. Rapid growth in pollution, increasing exposure of human hair to hazardous chemicals, and rapidly changing weather patterns have led to an increase in the prevalence of hair and scalp-related diseases across the globe. The individuals infected with these diseases or issues are spending on highly effective protein shampoo products, as they are formulated to be very mild, and non-irritating products that help to minimize hair and scalp-related diseases. For instance, in April 2020, according to the American Academy of Dermatology Association article, a US-based Peer-reviewed journal, on average, 80 million people suffer from hair issues, where around 50 million are men and 30 million are women a year in the United States. Therefore, the increasing prevalence of hair and scalp-related diseases is expected to boost demand for protein shampoo during the forecast period. Major players in the protein shampoo market are L’Oréal, Procter & Gamble, Unilever, Shiseido Company Limited, The Estée Lauder Companies Inc., Keratin Complex, Atlantic Coast Brands, McBride Research Laboratories Inc., PureBiology, Klorane, Kohli Herbal Products, KeraGreen, CavinKare Group, Amishi Consumer Technologies Private Limited (The Moms Co.), Herbario Cosmetics Private Limited, and Skin Secrets. Product innovation is the key trend gaining popularity in the protein shampoo market. Major companies operating in the protein shampoo market are focused on developing new product innovations to strengthen their position in the market. For instance, in May 2022, Medimix, the flagship brand of AVA Group, an Indian-based company manufacturing protein shampoos launched its total care shampoo in the hair care portfolio. Total care shampoo consists of wheat protein and other nine natural herbs such as tea tree oil, rosemary oil, neem, wild ginger, and others in a unique formula, which will help in minimizing hair loss, acting as anti-dandruff, and conditioning hair. In July 2022, Henkel, a Germany-based beauty care brand, acquired Shiseido's Professional hair business for an undisclosed amount. This acquisition combines two successful premium brands resulting in an alluring portfolio and an innovative combination of Western and Asian beauty knowledge, innovation, and education. Shiseido is a Japan-based cosmetics company that offers hair care products including protein shampoo. North America was the largest region in the protein shampoo market in 2022, and it is also expected to be the fastest-growing region in the forecast period. The regions covered in the protein shampoo market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the protein shampoo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The protein shampoo market consists of sales of shampoo that contains hydrolyzed (wheat, oat, soy) protein, hydrolyzed vegetable protein, hydrolyzed keratin, and hydrolyzed collagen. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The protein shampoo market research report is one of a series of new reports from The Business Research Company that provides protein shampoo market statistics, including protein shampoo industry global market size, regional shares, competitors with a protein shampoo market share, detailed protein shampoo market segments, market trends and opportunities, and any further data you may need to thrive in the protein shampoo industry. This protein shampoo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Vegan cosmetics are beauty products that are manufactured without the use of animal-derived raw materials. Vegan cosmetics are used for the enhancement of beauty without causing the skin damage that is caused by the use of artificial ingredients. The main types of products in vegan cosmetics are skin care, hair care, color cosmetics, and other products. Skincare is used for cleaning, soothing, restoring, reinforcing, protecting, and treating the skin and keeping it in good condition. These are made of organic and conventional natural products and are used by various customers, such as women, men, unisex, and kids. It is distributed through several channels, such as hypermarkets and supermarkets, specialty stores, e-commerce, and others. The global vegan cosmetics market is segmented – 1) By Product: Skin Care, Hair Care, Color Cosmetics, Other Products 2) By Nature: Organic, Conventional 3) By Customer Orientation: Women, Men, Unisex, Kids 4) By Distribution Channel: Hypermarkets and Supermarkets, Specialty Stores, E-commerce, Other Distribution Channles The global vegan cosmetics market size will grow from $15.97 billion in 2022 to $17.37 billion in 2023 at a compound annual growth rate (CAGR) of 8.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of vegan cosmetics is expected to grow to $22.63 billion in 2027 at a CAGR of 6.8%. The emerging popularity of veganism is expected to drive the growth of the vegan cosmetics market going forward. Veganism refers to abstaining from using products that are made from animals. A lot of animal abuse and animal cruelty are involved in making cosmetics. Therefore, people have been going vegan and preferring plant-based products to avoid being part of this animal cruelty. For instance, In October 2021, according to Vegan Beauty Takeover report, released by The Vegan Society it is estimated that over 80% of all the new vegan items were launched in the beauty category in 2020. Furthermore, according to Vegetarian Times, a US-based publication focused on food, culture, and lifestyle for vegetarians, in 2022, 9.7 million Americans will follow a vegetarian diet, and one million of whom will be vegan. Also, women make up 59% of plant-based eaters, while men make up 41%. Therefore, the emerging popularity of veganism is driving the demand for the vegan cosmetics market. Major players in the vegan cosmetics market are MuLondon, Loreal SA, Beauty Without Cruelty, Nature's Gat, MO MI BEAUTY, Eyes Lips Face, COTY Company, Gabriel Cosmetics Inc., Groupe Rocher, Pacifica Beauty, Billy Jealousy, Zuzu Luxe, Emma Jean Cosmetics, Modern Mineral Makeup, Arbonne International. Product innovation is the key trend gaining popularity in the vegan cosmetics market. Major companies operating in the vegan cosmetic market are focused on developing new and innovative vegan products to strengthen their market position. For instance, in June 2022, LG Household & Health Care, a South Korea-based consumer goods company, launched Freshian, a vegan-certified color cosmetic brand, in an effort to attract millennial and Generation Z beauty clients. This brand is introduced with two different types of cushion compacts, a variety of lip balms, and a sunscreen. The products' components, including five different forms of hyaluronic acid and madecassoside, were chosen to soothe the skin. Corn starch is used in the cushion puffs, and raw materials generated from sugarcane are used in the packaging to lessen the brand's environmental effect. In February 2022, Revolution Beauty Group, a UK-based developer and distributor of cruelty-free cosmetics, acquired Badass with a Heart (BH) cosmetics for a deal amount of $22.5 million. The acquisition would assist Revolution Beauty Group in expanding the BH brand domestically, globally, and in the vegan market. BH Cosmetics is a US-based and vegan brand that provides cruelty-free natural make-up products. Europe was the largest region in the vegan cosmetics market in 2022. The regions covered in the vegan cosmetics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the vegan cosmetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The vegan cosmetics market consists of sales of blush, concealer, eye liner, eye shadow, foundation, lipstick, mascara. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The vegan cosmetics market research report is one of a series of new reports from The Business Research Company that provides vegan cosmetics market statistics, including global market size, regional shares, competitors with a vegan cosmetics market share, detailed vegan cosmetics market segments, market trends and opportunities, and any further data you may need to thrive in the vegan cosmetics industry. This anomaly detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vegan baking ingredients are used for baking various products that are good alternatives for artificial and processed ingredients and foods usually used in the baking industry. Vegan baking ingredients are components that do not contain any by-products or products derived from animals. The main types of vegan baking ingredients are starch, raising agent, emulsifier, baking powder, mixes, vegetable oil, colors and flavors, and enzymes. Starch is a carbohydrate used for thickening or stabilizing food products. The different nature of these products includes conventional vegan baking ingredients and organic vegan baking ingredients and are used for preparing products such as cakes and pastries, biscuits and cookies, and bread and buns. The global vegan baking ingredients market is segmented - 1) By Product Type: Starch, Raising Agent, Emulsifier, Baking Powder and Mixes, Vegetable Oil, Colors and Flavors, Enzymes, 2) By Nature: Conventional Vegan Baking Ingredients, Organic Vegan Baking Ingredients, 3) By Application: Cakes and Pastries, Biscuits and Cookies, Bread and Buns The global vegan baking ingredients market size grew from $1.67 billion in 2022 to $1.82 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The market size of global vegan baking ingredients market is expected to grow to $2.5 billion in 2027 at a CAGR of 8.3%. The growing health awareness and changing food preference is expected to propel the growth of the vegan baking ingredients market going forward. Health awareness is the knowledge and awareness of health, healthcare, medical needs, diseases, and preventive actions in general. Health awareness made people shift towards a vegan diet, as they are plant-based food and healthier forms of food one can consume. For instance, a survey published in The Times of India, an India-based daily newspaper found that the COVID-19 pandemic has altered Indian's perspectives on health, with 70% saying they prioritize food and lifestyle improvements in 2021 to manage both emotional and physical health. Further, a study conducted by Beneo, a German-based developer and producer of natural sources of food, feed, and pharmaceutical products found that in 2020, 6 out of 10 European consumers are taking active steps to make their nutrition healthier by substituting snacks with meals with good ingredients and nutritional value. Therefore, the growing health awareness and changing food preference is driving the vegan baking ingredients market. Major players in the vegan baking ingredients market are Associated British Foods plc, BASF SE, DuPont de Nemours, Inc., Ingredion EMEA, Döhler, Lallemand Baking, Bakels Group, Cargill Incorporated, Turtle Island Foods, Veganz Group AG, B&G Foods , CSM Ingredients, Koninklijke DSM N.V., Kerry Group plc, and Lesaffre. Product innovation is a key trend gaining popularity in the vegan baking ingredients market. Major companies operating in the vegan baking ingredients market are coming up with new and innovative innovations to serve their customers. For instance, in March 2020, Chloe’s, a US-based company operating in vegan food ingredients launched its new line of frozen non-dairy desserts named Chloe’s Oatmilk Pops, which is the first of its kind in the market. These new pops are made with clean-label ingredients that are dairy-free, plant-based, Non-GMO Project Verified, and gluten-free and have various environmental benefits. These first-to-market oat milk pops are available currently in three unique flavors. In March 2021, Dawn Foods, a US-based global bakery manufacturer and ingredients supplier acquired JABEX for an undisclosed amount. This acquisition helps Dawn Foods to increase its production footprint globally, get access to JABEX’S products which are complementary to Dawn Foods’s product portfolio, and to strengthen its operations and supply chain in Central and Eastern Europe. Additionally, Dawn Foods believe that JABEX can help them provide better services and meet the demands of their clients while strengthening its high-quality fruit-based product offerings. JABEX is a Poland-based, family-owned manufacturer specializing in high-quality fruit-based products for the bakery industry. Europe was the largest region in the vegan baking ingredients market share in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in global vegan baking ingredients market analysi report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the vegan baking ingredients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The vegan baking ingredients market consists of sales of apple cider vinegar, barley malt, and buckwheat flour. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The vegan baking ingredients market research report is one of a series of new reports from The Business Research Company that provides vegan baking ingredients market statistics, including vegan baking ingredients industry global market size, regional shares, competitors with a vegan baking ingredients market share, detailed vegan baking ingredients market segments, market trends and opportunities, and any further data you may need to thrive in the vegan baking ingredients industry. This vegan baking ingredients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.